These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 7915150

  • 1. Combination sucralfate and histamine2-antagonist therapy.
    Gales MA, Steadman BK.
    Ann Pharmacother; 1994 May; 28(5):597-600. PubMed ID: 7915150
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of stomach ulcer].
    Hudziak H.
    Gastroenterol Clin Biol; 1996 Jan; 20(1 Pt 2):S136-S142. PubMed ID: 8734382
    [No Abstract] [Full Text] [Related]

  • 3. First randomized controlled trial with sucralfate versus H2-antagonists in the treatment of duodenal ulcer non-responders to initial treatment with sucralfate.
    Dobrilla G, Amplatz S, Andreoli R, Vallaperta PA.
    Hepatogastroenterology; 1990 Apr; 37(2):239-41. PubMed ID: 2187788
    [No Abstract] [Full Text] [Related]

  • 4. The use and abuse of histamine H2-receptor antagonists.
    Milton-Thompson GJ.
    J R Nav Med Serv; 1977 Apr; 63(1):9-14. PubMed ID: 17005
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical importance of antagonists of histamine H2 receptors in gastroenterology].
    Carella G.
    Clin Ter; 1984 Mar 31; 108(6):525-9. PubMed ID: 6144411
    [No Abstract] [Full Text] [Related]

  • 6. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD.
    Yale J Biol Med; 1996 Mar 31; 69(3):211-24. PubMed ID: 9165690
    [Abstract] [Full Text] [Related]

  • 7. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
    Hentschel E.
    Wien Med Wochenschr; 1983 Mar 31; 133(4-5):104-7. PubMed ID: 6134397
    [No Abstract] [Full Text] [Related]

  • 8. Current status of maintenance therapy in peptic ulcer disease. The ACG Committee on FDA-Related Matters.
    Am J Gastroenterol; 1988 Jun 31; 83(6):607-17. PubMed ID: 2897783
    [No Abstract] [Full Text] [Related]

  • 9. Drug-use review program for concurrent histamine H2-receptor antagonist-sucralfate therapy.
    Kane MP, Briceland LL, Garris RE, Favreau BN.
    Am J Hosp Pharm; 1990 Sep 31; 47(9):2007-10. PubMed ID: 1977317
    [Abstract] [Full Text] [Related]

  • 10. [Experience in the use of losek (omeprazole) in gastroenterology].
    Maev IV, V'iuchnova ES, Lebedev EG, Dicheva DT, Ovsiannikova EV, Antonenko OM, Shchekina MI.
    Ter Arkh; 2001 Sep 31; 73(7):79-82. PubMed ID: 11523419
    [No Abstract] [Full Text] [Related]

  • 11. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
    Chassany O, Bergmann JF.
    Rev Prat; 1998 Apr 15; 48(8):893-8. PubMed ID: 11767336
    [No Abstract] [Full Text] [Related]

  • 12. [A new H2-receptor antagonist in the treatment of gastrointestinal diseases].
    Senfft U.
    Med Welt; 1982 Oct 29; 33(43):1516-8. PubMed ID: 6130463
    [No Abstract] [Full Text] [Related]

  • 13. [Indications and use of omeprazole in esophago-gastro-duodenal diseases].
    Martín de Argila C, Boixeda de Miquel D, Moreira Vicente V, García Plaza A.
    Rev Clin Esp; 1999 Nov 29; 199(11):729-39. PubMed ID: 10638238
    [No Abstract] [Full Text] [Related]

  • 14. [Use of sucralfate in the treatment of peptic ulcer].
    Grigor'ev PIa, Isakov VA, Iakovenko EP.
    Klin Med (Mosk); 1989 Jan 29; 67(1):98-102. PubMed ID: 2716262
    [No Abstract] [Full Text] [Related]

  • 15. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.
    Koch M, Dezi A, Ferrario F, Capurso I.
    Arch Intern Med; 1996 Nov 11; 156(20):2321-32. PubMed ID: 8911239
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of uncomplicated duodenal ulcer with an antacid-containing attapulgite. Effectiveness and tolerance in comparison with a H2 receptor antagonist].
    Mayer R, Sack W, Wagner W.
    Fortschr Med; 1985 Dec 05; 103(45):1055-8. PubMed ID: 2867015
    [No Abstract] [Full Text] [Related]

  • 17. [Famotidine (quamatel) for treatment of ulcer disease].
    Bogachev RS, Levina ZK.
    Khirurgiia (Mosk); 1999 Dec 05; (1):34. PubMed ID: 10050509
    [No Abstract] [Full Text] [Related]

  • 18. Contemporary medical therapy for gastroesophageal reflux disease.
    Fass R, Hixson LJ, Ciccolo ML, Gordon P, Hunter G, Rappaport W.
    Am Fam Physician; 1997 Jan 05; 55(1):205-12, 217-8. PubMed ID: 9012279
    [Abstract] [Full Text] [Related]

  • 19. [Effect of H2-receptor antagonist and proton pomp inhibitor on the treatment of acid-related disease].
    Kawai T, Yagi K, Moriyasu F.
    Nihon Rinsho; 2015 Jul 05; 73(7):1159-62. PubMed ID: 26165073
    [Abstract] [Full Text] [Related]

  • 20. [Experience in the use of sucralfate in patients with ulcers].
    Orlov VA, Chesnokova EV.
    Klin Med (Mosk); 1988 Jul 05; 66(7):72-4. PubMed ID: 3184832
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.